Company Filing History:
Years Active: 2011
Title: **Innovator David E. Spaner: Pioneering Research in Lymphoma Treatments**
Introduction
David E. Spaner, based in Saint Paul, Minnesota, is a notable inventor recognized for his contributions to medical research, particularly in the field of oncology. With a focus on enhancing treatments for cell lymphomas, Spaner's innovative approach has the potential to significantly improve patient outcomes.
Latest Patents
David E. Spaner holds a patent that revolutionizes methods for increasing the expression of cell surface molecules on CD5B cell lymphoma cells. This groundbreaking invention involves utilizing immune response modifiers to treat various types of CD5B cell lymphomas, including chronic lymphocytic leukemia and small lymphocytic lymphoma. The patent emphasizes the administration of immune response modifier compounds, notably agonists of TLR7 and TLR8, to subjects who require effective treatment.
Career Highlights
Spaner is affiliated with 3M Innovative Properties Company, where he applies his expertise in research and development to drive forward advancements in medical technology. His role in this esteemed company enables him to collaborate with other leading minds in the industry and platform groundbreaking healthcare innovations.
Collaborations
Throughout his career, David has worked alongside Richard L. Miller, fostering a collaborative environment that enhances creative solutions in medical research. Their teamwork has contributed significantly to the field of lymphoma treatment, showcasing the power of synergistic collaboration among professionals.
Conclusion
David E. Spaner exemplifies innovation within the medical sector, particularly in the treatment of lymphomas. His dedication to advancing healthcare through his patent and collaborations signifies a commitment to improving the quality of life for patients battling these challenging conditions. As he continues his work at 3M Innovative Properties Company, the industry looks forward to his future contributions and the positive impact they will have on patient care.